Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data

Prostate Cancer and Prostatic Diseases, Published online: 02 February 2021; doi:10.1038/s41391-021-00326-3Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data

Source: Prostate Cancer and Prostatic Diseases - February 2, 2021 Category: Urology & Nephrology Authors: Alberto Martini Anish B. Parikh John P. Sfakianos Francesco Montorsi Matthew D. Galsky William K. Oh Che-Kai Tsao Source Type: research